Short description
Eclipse Regenesis is a development-stage medical device company focused on harnessing the body’s own tissue regeneration capabilities.
Description
Eclipse Regenesis is a development-stage medical device company focused on harnessing the body’s own tissue regeneration capabilities to treat important diseases. Its flagship product, the Eclipse XL1 System™, utilizes distraction enterogenesis in a treatment designed to mechanically stimulate the body to produce new, fully-functional intestinal to address Short Bowel Syndrome (SBS). With the support of more than 15 years of scientific research and the participation of SBS thought leaders from around the world, the Eclipse Regenesis team is passionate about pioneering a restorative therapy for a disease state that has no cure today. The Eclipse XL1 System is an investigational device and is not currently available commercially in any region.
Total funding
$$3123123
Sign in for full access
Location
Menlo Park, California, United States, North America
Founded on
January 1, 2017
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$56378 - 90123
Sign in for full access
Investors
Noaccess, Uh Ohhhh, Noaccess, No Way
Sign in for full access
Founders
Andre Bessette, James Dunn, Tom Krummel